Natural Killer Cells in Human Cancer: From Biological Functions to Clinical Applications
Figure 3
NK cell-based immunotherapies. Overview of current approaches being tested in clinical settings. (a) Infusion of tumor-specific MAbs triggers an ADCC response. (b) ADCC can be potentiated with the coadministration of cytokines. (c) Autologous and (d) allogeneic transfer of NK cells, which can be manipulated ex vivo with different approaches.